Indomethacin HCL SR Pellets
Indomethacin HCL SR Pellets – Sustained-Release Multiparticulate Platform for NSAID Formulations. Rraynex Indomethacin HCL SR Pellets are engineered as a sustained-release pellet system for pharmaceutical manufacturers requiring controlled release characteristics for NSAID therapy portfolios.
Product overview
Indomethacin hydrochloride sustained-release pellets provide a multiparticulate approach to dosing where extended release behavior is required. Rraynex applies controlled coating and pelletization to support reproducible dissolution, uniform pellet size and reliable capsule filling. Technical specifications are available upon request.
Key characteristics
- Sustained-release pellet technology.
- Controlled coating and dissolution characteristics.
- Uniform pellet size for capsule filling.
- Suitable for modified-release formulation development.
Product specifications
- Product
- Indomethacin HCL SR Pellets
- Form
- sustained-release Pellets
- Therapeutic category
- NSAID
- Strength
- Agreed per project — share your target strength in the enquiry
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Indomethacin HCL SR Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities